You are now leaving Abacavir HSR Support. ViiV/GSK do not recommend, endorse or accept liability for sites controlled by third parties.
The Abacavir Hypersensitivity Reaction (ABC HSR) educational programme is a global risk minimisation measure that has the following aims:
- Maintaining low morbidity and mortality from ABC HSR in general, and to minimise the risk of ABC rechallenge in patients with clinically suspected HSR, regardless of HLA-B*5701 status.
- Increase understanding and awareness of ABC HSR by Healthcare professionals (HCPs) and expand on the information already included in the product labels.